BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2022 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 15, 2022 at 12:00 PM Eastern Time.... Read more
Educators and school officials encouraged to drive student awareness of state and regional science fairs for a chance to enter nation’s premier middle school STEM competition WALTHAM, Mass. & WASHINGTON–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Society for Science (the Society), today announced the Thermo Fisher Scientific... Read more
Q3 2022 reported revenue growth of 4.9% year-over-year (yoy); organic revenue growth of 12.7% Q3 2022 GAAP operating margin 20.6%; non-GAAP operating margin 22.4%, up 180 basis points yoy Q3 2022 GAAP EPS $0.59; non-GAAP EPS $0.66, up 4.8% yoy Given strong year-to-date performance and high backlog, Bruker is raising its FY 2022 guidance for... Read more
Announces $1.0 Billion Share Repurchase Program for Q4 2022 Separately Enters Into Agreement to Acquire The Binding Site Group WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today provided an update on capital deployment. Throughout the fourth quarter of 2022, Thermo Fisher expects to execute a... Read more
Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing Specialty Diagnostics Offering with Established Technologies Delivering Strong Clinical Value for Patients in a Rapidly Growing Diagnostics Segment WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 1, 2022. Third Quarter 2022 Highlights Third quarter revenue was $10.68 billion. Third quarter GAAP diluted earnings per share (EPS) was $3.79. Third quarter adjusted EPS was $5.08. Delivered... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2022 financial results before market opening on Thursday, November 3, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go... Read more
WASHINGTON, Oct. 20, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the third quarter 2022. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended September 30, 2022, net earnings were $1.6 billion, or $2.10 per diluted common share which represents a 36.0% year-over-year... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) the world leader in serving science, announced today that it has priced an offering of ¥109.5 billion aggregate principal amount (the “Offering”) of the following yen-denominated notes, each issued at par: ¥22,300,000,000 aggregate principal amount of its 0.853% Senior Notes due 2025 (the “2025... Read more